As the morning rush settles and we swing into midday trading, let's take a quick look at a few of the biggest trends circling Wall Street this early afternoon:
Can't Get Too Much Intel
Chipmaker Intel Corp (NASDAQ:INTC) made headlines yesterday with its $15 billion common stock offering to support AI consumer demand, and is doubling down today.
The equity has increased its offering to $20 billion, a per share price of $95. So far for 2026, INTC sports an impressive 161% lead, and today was last seen down 0.6% to trade at $96.98.
U.K. Jumps on the GLP-1 Train
The second-ever GLP-1 weight-loss drug has been approved by regulators in the U.K.! Don't be fooled by Eli Lilly And Co (NYSE:LLY) quiet trading performance this afternoon, as across the pond the company is cheering approval of its weight-loss drug Foundayo.
This advancement comes only two months after Novo Nordisk's (NVO) Wegovy snagged the first approval. LLY has climbed 14% since the start of the year.
Nvidia Expands GPU Operation
Nvidia Corp (NASDAQ:NVDA) stock is up 1.2% to trade at $219.26 today after revealed its latest open-source model for GPU computers and laptops, the first of what will likely become many backings for his bid to boost open-source AI models.
Nvidia stock is now up 17.4% in 2026, only 7% off its May 14 all-time high.
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, alerts, and much more.
